Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Shares Outstanding (2016 - 2025)

Healthcare Services (HCSG) has disclosed Shares Outstanding for 14 consecutive years, with $76.2 million as the latest value for Q1 2022.

  • On a quarterly basis, Shares Outstanding changed 0.26% to $76.2 million in Q1 2022 year-over-year; TTM through Mar 2022 was $76.2 million, a 0.26% change, with the full-year FY2021 number at $76.0 million, changed 0.28% from a year prior.
  • Shares Outstanding was $76.2 million for Q1 2022 at Healthcare Services, roughly flat from $76.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $76.2 million in Q1 2022 to a low of $75.2 million in Q1 2018.
  • A 5-year average of $75.7 million and a median of $75.7 million in 2020 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: increased 1.0% in 2018, then grew 0.26% in 2022.
  • Healthcare Services' Shares Outstanding stood at $75.3 million in 2018, then increased by 0.28% to $75.6 million in 2019, then rose by 0.32% to $75.8 million in 2020, then grew by 0.28% to $76.0 million in 2021, then rose by 0.2% to $76.2 million in 2022.
  • Per Business Quant, the three most recent readings for HCSG's Shares Outstanding are $76.2 million (Q1 2022), $76.0 million (Q4 2021), and $76.0 million (Q3 2021).